Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma
Open Access
- 1 May 2020
- journal article
- research article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 35 (3), 619-629
- https://doi.org/10.3904/kjim.2018.248
Abstract
Background/Aims: Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that plays a key role in Th2-mediated inflammation, both directly by promoting the proliferation of naive CD4 Th2 cells, and indirectly by activating dendritic cells (DCs). TSLP-activated DCs induce the expansion of chemoattractant receptor homologous molecule expressed on Th2 (CRTH2)(+) CD4+ Th2 memory cells, which undergo a Th2 response and express prostaglandin D2 (PGD2) synthase. CRTH2, a PGD2 receptor, is a selective Th2-cell surface marker. We investigated the effects of an anti-TSLP antibody (Ab) and a CRTH2 antagonist, as well as their mechanisms of action, in a mouse model of acute asthma. Methods: BALB/c mice were sensitized and challenged with ovalbumin. We then evaluated the effects of the administration of an anti-TSLP Ab either alone or together with a CRTH2 antagonist on cell counts, Th2 cytokine levels in bronchoalveolar fluid, and the levels of epithelium-derived cytokines such as TSLP, interleukin (IL) 33, and IL-25 in lung homogenates, as well as airway hyper-responsiveness (AHR). Results: Anti-TSLP Ab and the CRTH2 antagonist significantly attenuated eosinophilic airway inflammation, AHR, and the expression of Th2 cytokines. The expression of GATA-3 and the levels of IL-33 and IL-25 in lung tissues were affected by the combined anti-TSLP and CRTH2 antagonist treatment. Conclusions: These results suggest that the dual blockade of TSLP and CRTH2 may serve as an effective treatment target for eosinophilic asthma.Keywords
This publication has 43 references indexed in Scilit:
- Type-2 innate lymphoid cells in human allergic diseaseCurrent Opinion in Allergy and Clinical Immunology, 2014
- Innate and adaptive immune responses in asthmaNature Medicine, 2012
- Dynamic role of epithelium-derived cytokines in asthmaClinical Immunology, 2012
- Programming dendritic cells to induce TH2 and tolerogenic responsesNature Immunology, 2010
- Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sitesImmunological Reviews, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2008
- Maintenance and Polarization of Human TH2 Central Memory T Cells by Thymic Stromal Lymphopoietin-Activated Dendritic CellsImmunity, 2006
- TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligandThe Journal of Experimental Medicine, 2005
- Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in miceNature Immunology, 2005
- OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung InflammationThe Journal of Experimental Medicine, 2003